GP-Act III Acquisition (NASDAQ:GPAT) Trading 0.2% Higher – Time to Buy?

GP-Act III Acquisition Corp. (NASDAQ:GPATGet Free Report) shares rose 0.2% during mid-day trading on Thursday . The company traded as high as $10.77 and last traded at $10.77. Approximately 36,652 shares changed hands during mid-day trading, an increase of 126% from the average daily volume of 16,245 shares. The stock had previously closed at $10.75.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of GP-Act III Acquisition in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

View Our Latest Analysis on GP-Act III Acquisition

GP-Act III Acquisition Price Performance

The business’s fifty day simple moving average is $10.72 and its 200-day simple moving average is $10.66.

GP-Act III Acquisition (NASDAQ:GPATGet Free Report) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter.

Institutional Investors Weigh In On GP-Act III Acquisition

Several hedge funds have recently made changes to their positions in GPAT. Longfellow Investment Management Co. LLC bought a new stake in shares of GP-Act III Acquisition during the 3rd quarter valued at $83,000. Bank of America Corp DE purchased a new position in shares of GP-Act III Acquisition in the 3rd quarter worth about $85,000. Clear Street Group Inc. purchased a new position in shares of GP-Act III Acquisition in the 3rd quarter worth about $109,000. Clear Street LLC boosted its stake in GP-Act III Acquisition by 8,429.8% in the 2nd quarter. Clear Street LLC now owns 10,321 shares of the company’s stock worth $109,000 after purchasing an additional 10,200 shares in the last quarter. Finally, Cannon Global Investment Management LLC purchased a new stake in GP-Act III Acquisition during the 3rd quarter valued at about $111,000.

About GP-Act III Acquisition

(Get Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Further Reading

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.